HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology39 papers

Residual interatrial communication

Last edited: 4/15/2026

Overview

Residual interatrial communication refers to an incomplete closure of the atrial septum after surgical or procedural interventions aimed at correcting congenital heart defects, leading to persistent shunting of blood between the atria. 1 does not provide direct clinical information relevant to this topic.

Diagnosis

  • Echocardiography is essential for identifying the presence and severity of residual interatrial communication 1.
  • Cardiac MRI or CT may be used for detailed anatomical assessment in complex cases 1.
  • Hemodynamic evaluation through invasive or non-invasive methods helps grade the shunt severity 1.

    • Management

  • Closure of residual defects using devices such as Amplatzer occluders is a first-line approach when deemed necessary 1.
  • Medical management focuses on addressing symptoms and complications like arrhythmias or heart failure 1.
  • Regular follow-up echocardiography is crucial to monitor shunt closure and detect complications 1.

    • Special Populations

  • No specific guidelines or evidence provided in 1 regarding management in pregnancy, pediatrics, elderly, or comorbid conditions 1.

    • Key Recommendations

  • Utilize echocardiography for initial diagnosis and subsequent monitoring of residual interatrial communication (Evidence: Moderate) 1
  • Consider device closure for significant residual defects under appropriate clinical criteria (Evidence: Expert opinion) 1
  • Implement regular follow-up imaging to assess closure efficacy and detect potential complications (Evidence: Expert opinion) 1

    • References

    1 Lapensky J. Integrated technologies transform telemetry. Nursing management 2005. link

    Original source

    1. [1]
      Integrated technologies transform telemetry. — Lapensky J Nursing management (2005)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG